Gelesis
IPOHydrogel-Based Medical Devices for Weight Management
Boston, United States · $185.5M raised
- Headquarters
- Boston, Massachusetts
- Business Model
- B2B
- Website
- gelesis.com
- Total Funding
- $185.5M
- Last Round
- $84.0M Series DJan 2021
- Rounds
- 5
About
Italian biotech developing hydrogel-based medical devices for weight management and GI-related conditions.
Summary
Gelesis is a Biotech company based in Boston, United States. It has raised $185.5M in total across 5 rounds, most recently a $84.0M Series D round in Jan 2021. Investors include PureTech Health, OrbiMed and Vitruvian Partners.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2022
Sign up to see all 6 rounds
Series A through SPAC Merger — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gelesis"><img src="https://indexed.vc/api/badge/company/gelesis" alt="Gelesis on Indexed.vc" width="260" height="76" /></a>